首页> 外文会议>Conference of the American College of Veterinary Internal Medicine (ACVIM) >Individualizing Drug Therapy: Advances in the Pharmacodynamic Monitoring of Immunosuppressive Agents
【24h】

Individualizing Drug Therapy: Advances in the Pharmacodynamic Monitoring of Immunosuppressive Agents

机译:个性化药物治疗:免疫抑制剂的药物动力学监测进展

获取原文

摘要

For as long as veterinarians have been giving drugs to animals, it has been recognized that individual patients can respond to therapy in unpredictable ways. Most animals will respond as expected, but in some patients the drug will appear to be completely ineffective, and in others the drug will cause unacceptable side effects. While, in many patients, simple dose adjustments can be used to address the problem, sometimes a particular drug simply cannot be used in an individual patient. When dealing with serious diseases that require aggressive therapy, where a drug that is ineffective can lead to death from the undertreated disease, and a drug that is not tolerated can lead to death from adverse effects, there is a natural tendency for veterinariansto never want to again use a particular drug with which they have had an untoward experience. This is particularly true with the immunosuppressive agents, where the immune-mediated diseases being treated can often be severe and life-threatening, and thetherapeutic window that provides immunosuppression without adverse effects or excessive predisposition to infection is narrow. With these drugs, there is a tendency for veterinarians to play "musical medications," abandoning a drug that they have a badexperience with forever, and switching to a newer immunosuppressive agent, often one they have never used before. The reality, however, is that there is no single immunosuppressive agent that is perfect for treating every immune-mediated condition in every individual patient. Moreover, even in drugs that are effective and well-tolerated in an individual animal, there is no single dose rate that is suited to all patients.
机译:只要兽医都向动物吸毒,就已经认识到,个体患者可以以不可预测的方式响应治疗。大多数动物都会按预期进行响应,但在一些患者中,药物似乎完全无效,而且在别人中,药物将导致不可接受的副作用。虽然,在许多患者中,可以使用简单的剂量调整来解决问题,有时特定的药物根本不能用于个体患者。当处理需要侵袭治疗的严重疾病时,其中无效的药物可能导致未治疗的疾病死亡,并且不耐受的药物可能导致来自不利影响的死亡,兽医司机的自然趋势永远不会想要再次使用他们患有不乏经验的特定药物。对于免疫抑制剂尤其如此,其中治疗的免疫介导的疾病通常是严重的,危及生命的疾病,以及提供免疫抑制而没有不良反应或过度倾向于感染的杀伤症的嗜素窗口是狭窄的。通过这些药物,兽医倾向于发挥“音乐药物”,抛弃一种药物,使他们具有永远存在的化脓,并切换到更新的免疫抑制剂,通常以前从未使用过。然而,现实是没有单一免疫抑制剂,非常适合治疗每个患者的每种免疫介导的病症。此外,即使在单个动物中有效且良好耐受的药物中,也没有适合所有患者的单一剂量率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号